The Arab Drug Company (EGX:ADCI)

Market Cap	2.33B
Revenue (ttm)	1.19B
Net Income (ttm)	222.05M
Shares Out	12.00M
EPS (ttm)	18.50
PE Ratio	10.48
Forward PE	n/a
Dividend	4.17 (2.15%)
Ex-Dividend Date	Oct 28, 2025

Volume	38,438
Average Volume	8,334
Open	201.55
Previous Close	201.55
Day's Range	193.27 - 209.90
52-Week Range	67.05 - 249.98
Beta	0.59
RSI	29.38
Earnings Date	Feb 11, 2026

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 1,152
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ADCI

Financial Performance

In 2025, The Arab Drug Company's revenue was 1.12 billion, an increase of 42.35% compared to the previous year's 785.52 million. Earnings were 198.93 million, an increase of 125.18%.